SOPHiA GENETICS S.A.
SOPH
Cena:
$ 4.88
-0.17 (-3.37%)
Valuace
85
Růst
15
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
SOPHIA GENETICS ANNOUNCES MAJOR EXPANSION IN THE UNITED STATES WITH THE SIGNING OF TWO MAJOR INTEGRATED HEALTH SYSTEMS
10-02-2026
BOSTON AND ROLLE, SWITZERLAND, FEB. 10, 2026 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A GLOB...
Více zde
SOPHIA GENETICS PROVIDES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS, INITIATES 2026 GUIDANCE, AND ANNOUNCES EXECUTIVE TRANSITION PLAN
12-01-2026
THE COMPANY FINISHES 2025 WITH STRONG Q4 PERFORMANCE, EXPECTS 20-22% REVENUE GROWTH IN 2026, AND PRO...
Více zde
SOPHIA GENETICS AND MD ANDERSON ANNOUNCE STRATEGIC COLLABORATION TO ACCELERATE AI-DRIVEN PRECISION ONCOLOGY
07-01-2026
BOSTON AND HOUSTON, JAN. 7, 2026 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A GLOBAL LEADER IN...
Více zde
SOPHIA GENETICS AND COMPLETE GENOMICS INTEGRATE SEQUENCING AND AI ANALYTICS TO ACCELERATE ADOPTION OF PRECISION MEDICINE
11-11-2025
BOSTON , NOV. 11, 2025 /PRNEWSWIRE/ -- COMPLETE GENOMICS, A LEADING INNOVATOR IN GENOMIC SEQUENCING,...
Více zde
SOPHIA GENETICS AND ELEMENT BIOSCIENCES UNITE SEQUENCING POWER AND AI ANALYTICS TO ACCELERATE GLOBAL RESEARCH IN PRECISION MEDICINE
11-11-2025
BOSTON AND SAN DIEGO , NOV. 11, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A GLOBAL LEADER...
Více zde
SOPHIA GENETICS REPORTS THIRD QUARTER 2025 RESULTS AND INCREASES 2025 REVENUE GUIDANCE
04-11-2025
BOSTON AND ROLLE, SWITZERLAND , NOV. 4, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A GLOB...
Více zde
SOPHIA GENETICS TO ANNOUNCE FINANCIAL RESULTS FOR THIRD QUARTER 2025 ON NOVEMBER 4, 2025
21-10-2025
BOSTON AND ROLLE, SWITZERLAND , OCT. 21, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A GLO...
Více zde
A.D.A.M. INNOVATIONS AND SOPHIA GENETICS PARTNER TO ADVANCE LIQUID BIOPSY TESTING AND COMPANION DIAGNOSTICS FOR PRECISION ONCOLOGY IN JAPAN
16-10-2025
ROLLE, SWITZERLAND AND TOKYO , OCT. 16, 2025 /PRNEWSWIRE/ -- A.D.A.M. INNOVATIONS, JAPAN'S LEADING ...
Více zde
SOPHIA GENETICS LAUNCHES AI-POWERED DIGITAL TWINS TO ENHANCE INTELLIGENT DECISION-MAKING IN ONCOLOGY
16-10-2025
BOSTON AND ROLLE, SWITZERLAND , OCT. 16, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A LEA...
Více zde
MYRIAD GENETICS AND SOPHIA GENETICS TO DEVELOP AN INNOVATIVE COMPANION DIAGNOSTIC OFFERING IN LIQUID BIOPSY
23-09-2025
SALT LAKE CITY AND BOSTON , SEPT. 23, 2025 /PRNEWSWIRE/ -- MYRIAD GENETICS (NASDAQ: MYGN), A LEADE...
Více zde
MYRIAD GENETICS AND SOPHIA GENETICS TO DEVELOP AN INNOVATIVE COMPANION DIAGNOSTIC OFFERING IN LIQUID BIOPSY
23-09-2025
SALT LAKE CITY AND BOSTON, SEPT. 23, 2025 (GLOBE NEWSWIRE) -- MYRIAD GENETICS (NASDAQ: MYGN), A LEAD...
Více zde
SOPHIA GENETICS EXPANDS COLLABORATION WITH ASTRAZENECA TO ENHANCE DETECTION OF BREAST AND PROSTATE CANCER
22-09-2025
BOSTON , SEPT. 22, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), AN AI TECHNOLOGY COMPANY TR...
Více zde
SOPHIA GENETICS AND JESSA ZIEKENHUIS ANNOUNCE PRECISION ONCOLOGY PARTNERSHIP FROM THE EUROPEAN CONGRESS OF PATHOLOGY
05-09-2025
BOSTON AND ROLLE, SWITZERLAND , SEPT. 5, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CL...
Více zde
SOPHIA GENETICS REPORTS SECOND QUARTER 2025 RESULTS
05-08-2025
BOSTON AND ROLLE, SWITZERLAND, AUG. 5, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLOU...
Více zde
SOPHIA GENETICS EXPANDS COLLABORATION WITH ASTRAZENECA USING AI TO IMPROVE BREAST CANCER PATIENT OUTCOMES
05-08-2025
BOSTON AND ROLLE, SWITZERLAND , AUG. 5, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLOUD...
Více zde
SOPHIA GENETICS TO ANNOUNCE FINANCIAL RESULTS FOR SECOND QUARTER 2025 ON AUGUST 5, 2025
22-07-2025
BOSTON AND ROLLE, SWITZERLAND , JULY 22, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLO...
Více zde
SOPHIA GENETICS REPORTS FIRST QUARTER 2025 RESULTS
06-05-2025
BOSTON AND ROLLE, SWITZERLAND , MAY 6, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLOUD-...
Více zde
SOPHIA GENETICS ANNOUNCES EXPANDED COLLABORATION WITH ASTRAZENECA TO ACCELERATE LIQUID BIOPSY TESTING GLOBALLY FROM AACR
28-04-2025
BOSTON AND ROLLE, SWITZERLAND , APRIL 28, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CL...
Více zde
SOPHIA GENETICS TO ANNOUNCE FINANCIAL RESULTS FOR FIRST QUARTER 2025 ON MAY 6, 2025
22-04-2025
BOSTON AND ROLLE, SWITZERLAND , APRIL 22, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CL...
Více zde
PRECISION FOR MEDICINE PARTNERS WITH SOPHIA GENETICS TO EXPAND BIOPHARMA SERVICES WITH THE SOPHIA DDM™ PLATFORM AND ITS LIQUID BIOPSY CAPABILITIES
08-04-2025
THE PARTNERSHIP INTEGRATES ADVANCED AI-DRIVEN ANALYTICS AND CLINICAL TRIAL SOLUTIONS, EMPOWERING BIO...
Více zde
SOPHIA GENETICS ANNOUNCES TWO MILLION PATIENT CASES ANALYZED, MARKING A NEW MILESTONE FOR DATA-DRIVEN MEDICINE AT NVIDIA GTC
18-03-2025
BOSTON, MA AND ROLLE, SWITZERLAND , MARCH 18, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A...
Více zde
SOPHIA GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
04-03-2025
BOSTON AND ROLLE, SWITZERLAND , MARCH 4, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLOU...
Více zde
LEADING HEALTHCARE INSTITUTIONS ADOPT MSK-ACCESS® FOR LIQUID BIOPSY TESTING
24-02-2025
SOPHIA GENETICS ENABLES INSTITUTIONS ACROSS THE GLOBE TO LAUNCH WORLD-CLASS ONCOLOGY TESTING BOSTON,...
Více zde
SOPHIA GENETICS TO ANNOUNCE FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024 ON MARCH 4, 2025
18-02-2025
BOSTON AND ROLLE, SWITZERLAND , FEB. 18, 2025 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLO...
Více zde
SOPHIA GENETICS LAUNCHES COMPREHENSIVE MRD TRACKING CAPABILITIES
28-01-2025
THE CUTTING-EDGE ONCOPORTAL™ MUTATION TRACKER ADD-ON MODULE ENABLES PRECISION MONITORING OF EVOLVI...
Více zde
SOPHIA GENETICS LAUNCHES MSK-IMPACT® POWERED WITH SOPHIA DDM™ AT AMP 2024
21-11-2024
LAUNCH OF NEW APPLICATION ENABLES GLOBAL ACCESS TO HIGHLY RECOGNIZED SOLID TUMOR PROFILING ASSAY BOS...
Více zde
SOPHIA GENETICS PROMOTES ROSS MUKEN TO PRESIDENT AND APPOINTS GEORGE CARDOZA AS CHIEF FINANCIAL OFFICER
05-11-2024
BOSTON AND ROLLE, SWITZERLAND , NOV. 5, 2024 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLOUD...
Více zde
SOPHIA GENETICS REPORTS THIRD QUARTER 2024 RESULTS
05-11-2024
CLINICAL GROWTH REACCELERATES WITH RECORD ANALYSIS VOLUME; CASH BURN IMPROVES 39% BOSTON AND ROLLE, ...
Více zde
SOPHIA GENETICS TO ANNOUNCE FINANCIAL RESULTS FOR THIRD QUARTER 2024 ON NOVEMBER 5, 2024
22-10-2024
BOSTON AND ROLLE, SWITZERLAND , OCT. 22, 2024 /PRNEWSWIRE/ -- SOPHIA GENETICS (NASDAQ: SOPH), A CLO...
Více zde
SOPHIA GENETICS PRESENTS GROUND-BREAKING MULTIMODAL RESEARCH ON AI-DRIVEN PATIENT STRATIFICATION AT ESMO 2024
14-09-2024
RESEARCH HIGHLIGHTS THE USE OF MULTIMODAL MACHINE LEARNING TO IDENTIFY NON-SMALL CELL LUNG CANCER PA...
Více zde
Dokumenty nejsou k dispozici
